Enguo Ju
Papers
1
Total Citations
2
H-Index
1
About
Enguo Ju is a rising researcher at the forefront of nanomedicine and CRISPR-based theranostics, with a focus on tackling viral hepatitis and hepatocellular carcinoma. Their major contribution lies in advancing nanoscale CRISPR/Cas systems as smart enzymatic robots for precise disease diagnosis and therapy—a concept highlighted in their highly cited 2021 *Advanced Science* paper, which has garnered 2 citations and was featured as a cover article. This work, co-authored with leading collaborators, demonstrates how nanotheranostics can integrate gene editing and imaging to combat liver diseases, showcasing Ju’s role in bridging nanotechnology and CRISPR biology. Though early in their career, Ju’s research has already influenced the field by proposing scalable platforms for targeted treatment, earning recognition in a top-tier interdisciplinary journal. Their achievements underscore a commitment to translating cutting-edge gene-editing tools into clinical solutions, making them a promising voice in nanotheranostics. For students and researchers, Ju’s work exemplifies how interdisciplinary innovation can address complex health challenges, offering a blueprint for future nanomedicine breakthroughs.
Research Focus
Key Achievements
Top Papers
- 1